Be a founding engineer building production-grade AI systems for drug toxicity prediction, with the explicit goal of replacing lab and animal experiments. The output of your work will influence real drug programs, real capital allocation, and real patient outcomes. This is not a research toy.
The challenge
Drug toxicity is responsible for ~50% of drug program failures. Most “AI for drug safety” platforms fail because their data foundations are brittle, poorly curated, and non-reproducible.
Our Client is building the opposite:
deterministic, auditable, scalable data and ML systems that scientists and regulators can trust.
This role exists because this problem is too important to outsource to mediocre infrastructure.
The role
This is not a “data engineer who wires tools together.”
You will own the end-to-end data and inference systems that convert raw chemical, biological, and clinical data into:
You will work directly with ML researchers, lab scientists, and product but you are the technical authority on systems correctness, scalability, and reliability.
If you’ve never built infrastructure that had to be right, this will be uncomfortable.
What you’ll actually build
The level of expectation
You’ve likely done multiple of the following:
If your experience tops out at dashboards, pipelines glued together with fragile scripts, or academic prototypes, this is not the role.
Technical requirements (non-negotiable)
Who thrives here
Final reality check
This will be:
But if you’re the kind of engineer who wants to look back and say “I built the system that made this possible”, this is the right room.
Your consultant
As a Senior Recruitment Consultant at Aspire Life Sciences, Julien Funes' expertise lies at the nexus of technology and life sciences. He recruits top Machine Learning and data talent for Biotech and life sciences startups across Europe and North America. He is committed to advancing the industry by sourcing and securing top-tier talent for roles in these critical sectors. His approach enables him to effectively match candidates with opportunities where technological innovation meets life science excellence.